info@marketresearchfuture.com 📞 +1 628 258 0071(US)  📞 +44 2035 002 764(UK)
Gallbladder Treatment Market Research Report - Forecast till 2027

Gall bladder treatment market information, by disease indications (gallstones, cholecystitis and biliary colic, cholelithiasis and choledocholithiasis, gallbladder polyps, gall bladder cancer), by diagnosis (ultrasound, blood tests, computerized tomography (CT), cholangiography and hepatobiliary scintigraphy), by treatment (surgery, drugs), by end users (hospitals & gynecology clinics, academic & research centers) - Global forecast till 2027

ID: MRFR/Pharma/2643-CR | September 2017 | Region: Global | 94 pages

Gallbladder Treatment Market Speak to Analyst Request a Free Sample

Gallbladder Treatment Market Scenario


The gall bladder is a small pear-shaped located underneath the liver. Its main function is to store the bile produced by liver and pass it along through a duct that empties into the small intestine. Gall bladder diseases affect a large number of people in the world. Gallbladder and biliary related diseases occurred in about 104 million people (1.6%) in 2013 and they resulted in 106,000 deaths. The major driving factors for the growth of the market are increasing geriatric population, increasing prevalence rate of various gallbladder diseases, and introduction & adoption of advanced diagnostic treatment options. Moreover, increasing awareness of the diseases, rising healthcare expenditure, and rising demand from emerging markets of Asia have fuelled the market growth. However, pain and complications during surgery and asymptomatic nature of gallstones may slow the growth of the market.


The market for gall bladder treatment is growing at a healthy rate. The market is expected to grow at the CAGR of 6.5% during the forecast period and is estimated to reach USD 27121.5 million by 2023.


Figure- Global gall bladder treatment market, by diseases indication (2016) (%) gall bladder treatment market, by diseases indication


Source: American Gastroenterological Association, NCBI, Gastroenterological Society of Australia, British Society of Gastroenterology Directorate of Industries, Expert Interview Market Research Future Analysis, Annual report, White paper, Company Presentation


Key Findings



  • Ultrasound segment accounts for the largest market share in the global gall bladder treatment market while Computerized tomography (CT) segment is projected to grow at a CAGR of 7.10% during the forecast period from 2017 – 2023.

  • Surgery segment accounts for the largest market share in the global gall bladder treatment market by Treatment, this segment is expected to reach USD 1 in 2023

  • North Americas market is expected to reach USD 10,584.8 by 2023


Intended Audience



  • Gall Bladder Products Manufacturers

  • Gall Bladder Products Providers

  • Medical Research Laboratories

  • Research and Development (R&D) Companies

  • Market Research and Consulting Service Providers

  • Potential Investors


Research Methodology Research Methodology gallbladder treatment market


 Source: American Gastroenterological Association, NCBI, Gastroenterological Society of Australia, British Society of Gastroenterology Directorate of Industries, Expert Interview Market Research Future Analysis, Annual report, White paper, Company Presentation


 


Segments          


Global gall bladder treatment market has been segmented on the basis of disease indications, diagnosis, treatment and end users. On the basis of disease indications the market is segmented as gallstones, cholecystitis & biliary colic, cholelithiasis & choledocholithiasis, gallbladder polyps, gall bladder cancer. On the basis of diagnosis the market is categorized as ultrasound, blood tests, computerized tomography (CT), cholangiography and hepatobiliary scintigraphy and others. On the basis of treatment the market is segmented into surgery, and drugs and on the basis of end users the market is divided into hospitals & gynecology clinics, academic & research centers and others.


Regional analysis                    


Considering the global scenario of the market, North America dominates the global gall bladder treatment market owing to the presence of huge population suffering from gall bladder diseases. US holds the largest market share in North America gall bladder treatment market. In developed countries, 10–15% of adults have gallstones. Europe has the second largest market for the gall bladder treatment which is followed by Asia Pacific. Presence of well-developed healthcare sector and high healthcare expenditure, the gall bladder treatment market in Europe is growing at a CAGR of 6.8%. Asia Pacific is also witnessing a rapid growth in this market which is mainly due to rapidly increasing awareness of treatments, presence of huge population, rising healthcare expenditure and government support for research & development. Asia Pacific gall bladder treatment market is expected to grow at a CAGR of 7.0% during the forecasted period. The Middle East & Africa is expected to have limited growth.


Key players for global gall bladder treatment market                                           


Some of the major players in this market are: Boston Scientific Corporation, Intuitive Surgical, C. R. Bard, Inc., Dornier MedTech, Koninklijke Philips N.V., B. Braun Melsungen AG, Sanofi and others The report for Global Gall Bladder Treatment Market of Market Research Future comprises of extensive primary research along with the detailed analysis of qualitative as well as quantitative aspects by various industry experts, key opinion leaders to gain deeper insight to the market and industry performance. The report gives a clear picture of the current market scenario which includes historical and projected market size in terms of value and volume, technological advancement, macro economical and governing factors in the market. The report provides details information and strategies of the top key players in the industry. The report also gives a broad study of the different market segments and regions



Report Scope:
Report Attribute/Metric Details
  Market Size   USD 27121.5 Million
  CAGR   2017-2023: 6.5%
  Base Year   2019
  Forecast Period   2027
  Historical Data   2018
  Forecast Units   Value (USD Million)
  Report Coverage   Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
  Segments Covered   Disease Indications, Diagnosis, Treatment and End Users
  Geographies Covered   North America, Europe, Asia-Pacific, and Rest of the World (RoW)
  Key Vendors   Boston Scientific Corporation, Intuitive Surgical, C. R. Bard, Inc., Dornier MedTech, Koninklijke Philips N.V., B. Braun Melsungen AG, Sanofi and others
  Key Market Opportunities

  • Asia pacific. Presence of well-developed healthcare sector and high healthcare expenditure
  • Increasing awareness of treatments, presence of huge population
  • Rising healthcare expenditure and government support for research & development
  •   Key Market Drivers

  • Increasing geriatric population
  • Increasing prevalence rate of various gallbladder diseases
  • Introduction & adoption of advanced diagnostic treatment options


  • Speak to Analyst Ask for Customization